資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://tkuir.lib.tku.edu.tw/dspace/handle/987654321/118637
|
| 題名: | Effect of Proton Pump Inhibitors on Mortality of Cirrhotic Patients with Pneumonia |
| 作者: | Hung, Tsung-Hsing;Tseng, Chih -Wei;Tsai, Chih-Chun;Lee, Hsing-Feng |
| 日期: | 2019-04-25 |
| 上傳時間: | 2020-06-01 12:10:39 (UTC+8) |
| 摘要: | Objective
Pneumonia is life-threatening in patients with liver cirrhosis. Proton pump inhibitors (PPIs)
may increase the risk of these patients developing pneumonia. However, whether PPIs
increase mortality in patients with cirrhosis and pneumonia remain unknown.
Methods
We used the Taiwan National Health Insurance Database to enroll 1,201 cirrhotic patients
with pneumonia without active gastrointestinal bleeding who were receiving PPIs and were
hospitalized between January 1, 2010 and December 31, 2013. A one-to-three propensity
score match was performed to select a comparison group based on age, gender, and
comorbid disorders.
Results
The overall 30-day and 90-day all-cause mortality rates were 13.7% and 26.9% in the PPI
group, and 14.3% and 25.1% in the non-PPI group, respectively. After Cox regression
model adjusting for age, gender, and comorbid disorders, the hazard ratios of the effect of
PPIs on 30-day and 30 to 90-day mortality were 0.94 (95% Confidence Interval [CI], 0.79–
1.12, P = 0.468) and 1.26 (95% CI, 1.05–1.52; P = 0.013), respectively.
Conclusions
PPIs were not associated with 30-day mortality among cirrhotic patients with pneumonia but
not active gastrointestinal bleeding. However, prolonged PPI therapy may be associated
with higher mortality. |
| 關聯: | PLoS One 14(4), e0216041 |
| DOI: | 10.1371/journal.pone.0216041 |
| 顯示於類別: | [應用數學與數據科學學系] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| Effect of Proton Pump Inhibitors on Mortality of Cirrhotic Patients with Pneumonia.pdf | | 520Kb | Adobe PDF | 1 | 檢視/開啟 | | index.html | | 0Kb | HTML | 126 | 檢視/開啟 |
|
在機構典藏中所有的資料項目都受到原著作權保護.
|
